Clinical Trials Directory

Trials / Completed

CompletedNCT03571464

Study of the Efficacy of GGRO: a Novel Cognitive Training App

Can Brief, Daily Training Using a Mobile Applications Help Change Maladaptive Beliefs? A Cross-over Randomized-control Study Evaluating the Efficacy of GGRO in Reducing Maladaptive Beliefs and Obsessive-compulsive Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
97 (actual)
Sponsor
University of Valencia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the present study was to evaluate the efficacy of GGRO reducing OCD related maladaptive beliefs and OCD symptoms. Specifically, a randomized controlled trial with crossover design was carried out in non-clinical population to assess pre-post changes in levels of OCD-related maladaptive beliefs and OCD symptoms, including relationship OCD (ROCD) symptoms, self-esteem, and depressive symptoms following 15 days of using GGRO.

Detailed description

The implementation of Information and Communication Technologies in the treatment or prevention of OCD symptoms has been significantly lower compared to with its application in other anxiety disorders. Recently, an exploratory study evaluated a brief, game-like, training exercise for challenging OCD-beliefs delivered via a mobile application platform named GGRO. However, more studies are needed to test the efficacy.

Conditions

Interventions

TypeNameDescription
DEVICEGGRO Mobile AppGGRO was designed to challenge maladaptive beliefs that underlie common OCD symptoms (e.g., contamination, repugnant thoughts) as well as relationships obsessions. Users are presented with 'blocks' featuring statements such as "I take things as they come" or "Everything can end in a catastrophe". Users then have to respond to these statements by either pulling 'blocks' towards themselves (i.e., downwards) or throwing the blocks away from themselves (i.e., rejecting them upwards).

Timeline

Start date
2016-09-25
Primary completion
2017-06-10
Completion
2017-07-25
First posted
2018-06-27
Last updated
2018-06-29

Source: ClinicalTrials.gov record NCT03571464. Inclusion in this directory is not an endorsement.